The earnings call highlighted significant improvements in gross margin, cash flow, and cost efficiency, alongside successful new product developments and strategic M&A integration. However, challenges such as revenue decline, regulatory issues, and a decrease in B2C revenue were noted. Despite these challenges, the company's positive adjusted EBITDA and improved financial metrics demonstrate progress towards profitability.

Company Guidance

During the second quarter of 2025, CV Sciences reported revenue of $3.6 million, maintaining consistency with Q1 2025. The company achieved a gross margin of 50.9%, the highest since 2019, marking an improvement from the previous quarter's 46%. This performance was bolstered by the company's M&A strategy, particularly the acquisition of Elevated Softgels, which enhanced in-house manufacturing capabilities and contributed to cost efficiencies. The second quarter also saw a positive adjusted EBITDA of $59,000, a significant recovery from the previous year's losses. CV Sciences continues to lead in the natural product retail channel and is expanding its product offerings to include non-cannabinoid items under the PlusHLTH brand. Furthermore, the investment in Cultured Foods has led to the launch of Lunar Fox, a new line of plant-based foods. The company has made strides in reducing SG&A expenses by 20% year-over-year, aligning its cost structure to support growth and profitability amidst a challenging regulatory environment.

Improved Gross Margin

Q2 gross margin of 50.9%, a significant improvement compared to Q1 2025 gross margin of 46% and the highest since 2019.

Positive Adjusted EBITDA

Achieved a positive adjusted EBITDA of $59,000, marking the first positive adjusted EBITDA since Q2 2019.

Cost Efficiency Gains

SG&A expenses decreased by 20% year-over-year, and cost structure improvements led to significant cash savings.

New Product Development Success

New products introduced since 2023 represented 39% of revenue for Q2 2025, highlighting successful product innovation.

Increased Market Share

Maintained #1 position in natural product retail channel and increased market share.

Cash Flow Improvement

Generated positive cash from operating activities of $0.3 million in Q2 2025, significantly improved from cash used in operations in Q2 2024.

Strategic M&A Integration

Realized efficiency gains and expected further cost efficiency and gross margin improvement from the acquisition of Elevated Softgels.

CV Sciences (CVSI) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

CVSI Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 17, 2025	2025 (Q3)	- / -	-0.002	―	―	―
Aug 13, 2025	2025 (Q2)	- / >-0.01	-0.003	66.67% (<+0.01)	―
May 09, 2025	2025 (Q1)	- / >-0.01	-0.004	75.00% (<+0.01)	―	―
Mar 27, 2025	2024 (Q4)	- / >-0.01	-0.005	20.00% (<+0.01)	―
Nov 14, 2024	2024 (Q3)	- / >-0.01	-0.003	33.33% (<+0.01)	―
Aug 13, 2024	2024 (Q2)	- / >-0.01	-0.01	70.00% (<+0.01)	―
May 14, 2024	2024 (Q1)	- / >-0.01	0.04	-110.00% (-0.04)	―
Mar 28, 2024	2023 (Q4)	- / >-0.01	-0.01	50.00% (<+0.01)	―
Nov 14, 2023	2023 (Q3)	- / >-0.01	-0.01	70.00% (<+0.01)	―
Aug 14, 2023	2023 (Q2)	- / -0.01	-0.03	66.67% (+0.02)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

CVSI Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 13, 2025	$0.04	$0.04	0.00%
May 09, 2025	$0.03	$0.03	0.00%
Mar 27, 2025	$0.03	$0.03	0.00%
Nov 14, 2024	$0.04	$0.04	0.00%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does CV Sciences Inc (CVSI) report earnings?

CV Sciences Inc (CVSI) is schdueled to report earning on Nov 17, 2025, TBA (Confirmed).

What is CV Sciences Inc (CVSI) earnings time?

CV Sciences Inc (CVSI) earnings time is at Nov 17, 2025, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is CVSI EPS forecast?

Currently, no data Available

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing